January 9, 2019
Cellular Biomedicine to gather patients to test its CAR-T therapy for multiple myeloma in China
Cellular Biomedicine Group (CBMG) will begin picking the patients to test anti-BCMA CAR-T therapy targeting relapsed and refractory Multiple Myeloma in China.